Olympus has announced and exclusive Japan distribution agreement covering VisEn's fluorescence molecular tomography (FMT) imaging systems and portfolio of in vivo near infrared fluorescence probes. Olympus will commence sales of the products from September 1, 2006.

By combining the VisEn products with the Olympus OV100 and IV100 molecular imaging systems, it will be possible to generate an unprecedented range of molecular imaging data in vivo, from the cellular and tissue levels to the quantification of molecular activities real time in the whole body.

These products will accelerate progress in disease research and in drug development by significantly expanding molecular imaging applications and enhancing data quality in diseases including cancer, inflammation, cardiovascular disease, and bone disease.

http://www.gzjiayumed.com/en/index.asp